Literature DB >> 22999954

Enthalpic barriers dominate the folding and unfolding of the human Cu, Zn superoxide dismutase monomer.

Can Kayatekin1, Noah R Cohen, C Robert Matthews.   

Abstract

The rate-limiting step in the formation of the native dimeric state of human Cu, Zn superoxide dismutase (SOD1) is a very slow monomer folding reaction that governs the lifetime of its unfolded state. Mutations at dozens of sites in SOD1 are known to cause a fatal motor neuron disease, amyotrophic lateral sclerosis, and recent experiments implicate the unfolded state as a source of soluble oligomers and histologically observable aggregates thought to be responsible for toxicity. To determine the thermodynamic properties of the transition state ensemble (TSE) limiting the folding of this high-contact-order β-sandwich motif, we performed a combined thermal/urea denaturation thermodynamic/kinetic analysis. The barriers to folding and unfolding are dominated by the activation enthalpy at 298 K and neutral pH; the activation entropy is favorable and reduces the barrier height for both reactions. The absence of secondary structure formation or large-scale chain collapse prior to crossing the barrier for folding led to the conclusion that dehydration of nonpolar surfaces in the TSE is responsible for the large and positive activation enthalpy. Although the activation entropy favors the folding reaction, the transition from the unfolded state to the native state is entropically disfavored at 298 K. The opposing entropic contributions to the free energies of the TSE and the native state during folding provide insights into structural properties of the TSE. The results also imply a crucial role for water in governing the productive folding reaction and enhancing the propensity for the aggregation of SOD1.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22999954      PMCID: PMC3712906          DOI: 10.1016/j.jmb.2012.09.009

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  62 in total

1.  Desolvation is a likely origin of robust enthalpic barriers to protein folding.

Authors:  Zhirong Liu; Hue Sun Chan
Journal:  J Mol Biol       Date:  2005-04-15       Impact factor: 5.469

Review 2.  Structure, folding, and misfolding of Cu,Zn superoxide dismutase in amyotrophic lateral sclerosis.

Authors:  Rishi Rakhit; Avijit Chakrabartty
Journal:  Biochim Biophys Acta       Date:  2006-05-22

3.  Enthalpy-entropy compensation: a phantom or something useful?

Authors:  Evgeni B Starikov; Bengt Nordén
Journal:  J Phys Chem B       Date:  2007-11-29       Impact factor: 2.991

Review 4.  Win some, lose some: enthalpy-entropy compensation in weak intermolecular interactions.

Authors:  J D Dunitz
Journal:  Chem Biol       Date:  1995-11

5.  Amyotrophic lateral sclerosis mutations have the greatest destabilizing effect on the apo- and reduced form of SOD1, leading to unfolding and oxidative aggregation.

Authors:  Yoshiaki Furukawa; Thomas V O'Halloran
Journal:  J Biol Chem       Date:  2005-02-03       Impact factor: 5.157

6.  The structure of holo and metal-deficient wild-type human Cu, Zn superoxide dismutase and its relevance to familial amyotrophic lateral sclerosis.

Authors:  Richard W Strange; Svetlana Antonyuk; Michael A Hough; Peter A Doucette; Jorge A Rodriguez; P John Hart; Lawrence J Hayward; Joan S Valentine; S Samar Hasnain
Journal:  J Mol Biol       Date:  2003-05-09       Impact factor: 5.469

7.  Zinc binding modulates the entire folding free energy surface of human Cu,Zn superoxide dismutase.

Authors:  Can Kayatekin; Jill A Zitzewitz; C Robert Matthews
Journal:  J Mol Biol       Date:  2008-09-26       Impact factor: 5.469

8.  Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1.

Authors:  L I Bruijn; M K Houseweart; S Kato; K L Anderson; S D Anderson; E Ohama; A G Reaume; R W Scott; D W Cleveland
Journal:  Science       Date:  1998-09-18       Impact factor: 47.728

Review 9.  Amyotrophic lateral sclerosis associated with mutations in the CuZn superoxide dismutase gene.

Authors:  Peter M Andersen
Journal:  Curr Neurol Neurosci Rep       Date:  2006-01       Impact factor: 5.081

10.  A spectroscopic characterization of a monomeric analog of copper, zinc superoxide dismutase.

Authors:  I Bertini; M Piccioli; M S Viezzoli; C Y Chiu; G T Mullenbach
Journal:  Eur Biophys J       Date:  1994       Impact factor: 1.733

View more
  6 in total

1.  Microsecond barrier-limited chain collapse observed by time-resolved FRET and SAXS.

Authors:  Sagar V Kathuria; Can Kayatekin; Raul Barrea; Elena Kondrashkina; Rita Graceffa; Liang Guo; R Paul Nobrega; Srinivas Chakravarthy; C Robert Matthews; Thomas C Irving; Osman Bilsel
Journal:  J Mol Biol       Date:  2014-03-04       Impact factor: 5.469

2.  Nonnative structure in a peptide model of the unfolded state of superoxide dismutase 1 (SOD1): Implications for ALS-linked aggregation.

Authors:  Noah R Cohen; Jill A Zitzewitz; Osman Bilsel; C Robert Matthews
Journal:  J Biol Chem       Date:  2019-07-24       Impact factor: 5.157

3.  Cosolutes, Crowding, and Protein Folding Kinetics.

Authors:  Annelise H Gorensek-Benitez; Austin E Smith; Samantha S Stadmiller; Gerardo M Perez Goncalves; Gary J Pielak
Journal:  J Phys Chem B       Date:  2017-06-29       Impact factor: 2.991

4.  Friction-Limited Folding of Disulfide-Reduced Monomeric SOD1.

Authors:  Noah R Cohen; Can Kayatekin; Jill A Zitzewitz; Osman Bilsel; C R Matthews
Journal:  Biophys J       Date:  2020-03-12       Impact factor: 4.033

5.  Tryptophan 32-mediated SOD1 aggregation is attenuated by pyrimidine-like compounds in living cells.

Authors:  Edward Pokrishevsky; Luke McAlary; Natalie E Farrawell; Beibei Zhao; Mine Sher; Justin J Yerbury; Neil R Cashman
Journal:  Sci Rep       Date:  2018-10-22       Impact factor: 4.379

6.  Computational Insights into the Unfolding of a Destabilized Superoxide Dismutase 1 Mutant.

Authors:  Stepan Timr; Fabio Sterpone
Journal:  Biology (Basel)       Date:  2021-11-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.